Philadelphia chromosome-negative chronic myelogenous leukemia and chronic myelomonocytic leukemia. Hematol Oncol Clin North Am 1990 Apr;4(2):389-404
Date
04/01/1990Pubmed ID
2182598DOI
10.1016/s0889-8588(18)30494-5Scopus ID
2-s2.0-0025253450 (requires institutional sign-in at Scopus site) 45 CitationsAbstract
Philadelphia chromosome (Ph)-negative chronic myelogenous leukemia (CML) and chronic myelomonocytic leukemia (CMML) are heterogeneous disorders characterized by various degrees of proliferation, dysplasia, maturation arrest, and monocytosis. In this article, the clinical, laboratory, molecular, and therapeutic aspects of the disease entities are reviewed.
Author List
Kantarjian HM, Kurzrock R, Talpaz MAuthor
Razelle Kurzrock MD Center Associate Director, Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AgedAntineoplastic Agents
Bone Marrow Transplantation
Cohort Studies
Combined Modality Therapy
Female
Humans
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
Leukemia, Myelomonocytic, Chronic
Male
Middle Aged
Oncogenes
Prognosis
Risk Factors